Hemoglobin Mass and Blood Volume in Patients With Altitude-Related Polycythemia

Patients with chronic mountain sickness (CMS) have a high hemoglobin concentration [Hb] due to increased hemoglobin mass (Hbmass) and possibly reduced plasma volume (PV). The values of Hbmass, PV and blood volume (BV) have been described differently, and the relationships between [Hb] and Hbmass or...

Full description

Bibliographic Details
Main Authors: Walter F. J. Schmidt, Nadine Wachsmuth, Jesus Jimenez, Rudy Soria
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Physiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphys.2022.867108/full
_version_ 1818150083600842752
author Walter F. J. Schmidt
Nadine Wachsmuth
Jesus Jimenez
Rudy Soria
author_facet Walter F. J. Schmidt
Nadine Wachsmuth
Jesus Jimenez
Rudy Soria
author_sort Walter F. J. Schmidt
collection DOAJ
description Patients with chronic mountain sickness (CMS) have a high hemoglobin concentration [Hb] due to increased hemoglobin mass (Hbmass) and possibly reduced plasma volume (PV). The values of Hbmass, PV and blood volume (BV) have been described differently, and the relationships between [Hb] and Hbmass or PV are poorly understood. This study obtained representative Hbmass, PV and BV data from healthy, high-altitude residents and CMS patients and quantified the dependency of [Hb] on Hbmass and PV. Methods: Eighty-seven subjects born at high altitude (∼3,900 m) were enrolled. Thirty-four had CMS (CMS), 11 had polycythemia without CMS (intermediate, IM), 20 were healthy highlanders (HH), and 22 living near sea level (SL, 420 m) served as the sea level (SL) control group. Hbmass, PV and BV were determined using a CO-rebreathing method modified for assessing polycythemia patients. Furthermore, [Hb], hematocrit (Hct), plasma erythropoietin concentration [EPO] and blood gas and acid–base status were determined. Results: In the HH group, Hbmass was 27% higher (940 ± 105 g) than in the SL group (740 ± 112 g) and 72% (1,617 ± 265 g) lower than in the CMS group. The PV in the HH group was similar to that in the SL group (−6%) and 15% higher than that in the CMS group (p < 0.001). In the HH group, the BV (5,936 ± 673 ml) did not differ from that in the SL group and was 28% lower than in the CMS group (7,606 ± 1075 ml, p < 0.001). Log [EPO] was slightly increased in the CMS group relative to the HH group (p < 0.01). All values in the IM group were between those in the HH and CMS groups. Hbmass and BV were positively correlated, and PV was negatively correlated with peripheral O2 saturation. Increased Hbmass and decreased PV contributed approximately 65 and 35%, respectively, to the difference in [Hb] between the HH (17.1 ± 0.8 g/dl) and CMS (22.1 ± 1.0 g/dl) groups. Conclusions: In CMS patients, the decrease in PV only partially compensated for the substantial increase in Hbmass, but it did not prevent an increase in BV; the decrease in PV contributed to an excessively high [Hb].
first_indexed 2024-12-11T13:17:18Z
format Article
id doaj.art-22ca8831e4394e71a4fd86a0408d65d7
institution Directory Open Access Journal
issn 1664-042X
language English
last_indexed 2024-12-11T13:17:18Z
publishDate 2022-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Physiology
spelling doaj.art-22ca8831e4394e71a4fd86a0408d65d72022-12-22T01:05:59ZengFrontiers Media S.A.Frontiers in Physiology1664-042X2022-04-011310.3389/fphys.2022.867108867108Hemoglobin Mass and Blood Volume in Patients With Altitude-Related PolycythemiaWalter F. J. Schmidt0Nadine Wachsmuth1Jesus Jimenez2Rudy Soria3Department of Sports Medicine and Sports Physiology, University of Bayreuth, Bayreuth, GermanyDepartment of Sports Medicine and Sports Physiology, University of Bayreuth, Bayreuth, GermanyInstituto Boliviano de Biologia de Altura, Universidad Mayor de San Andres, La Paz, BoliviaInstituto Boliviano de Biologia de Altura, Universidad Mayor de San Andres, La Paz, BoliviaPatients with chronic mountain sickness (CMS) have a high hemoglobin concentration [Hb] due to increased hemoglobin mass (Hbmass) and possibly reduced plasma volume (PV). The values of Hbmass, PV and blood volume (BV) have been described differently, and the relationships between [Hb] and Hbmass or PV are poorly understood. This study obtained representative Hbmass, PV and BV data from healthy, high-altitude residents and CMS patients and quantified the dependency of [Hb] on Hbmass and PV. Methods: Eighty-seven subjects born at high altitude (∼3,900 m) were enrolled. Thirty-four had CMS (CMS), 11 had polycythemia without CMS (intermediate, IM), 20 were healthy highlanders (HH), and 22 living near sea level (SL, 420 m) served as the sea level (SL) control group. Hbmass, PV and BV were determined using a CO-rebreathing method modified for assessing polycythemia patients. Furthermore, [Hb], hematocrit (Hct), plasma erythropoietin concentration [EPO] and blood gas and acid–base status were determined. Results: In the HH group, Hbmass was 27% higher (940 ± 105 g) than in the SL group (740 ± 112 g) and 72% (1,617 ± 265 g) lower than in the CMS group. The PV in the HH group was similar to that in the SL group (−6%) and 15% higher than that in the CMS group (p < 0.001). In the HH group, the BV (5,936 ± 673 ml) did not differ from that in the SL group and was 28% lower than in the CMS group (7,606 ± 1075 ml, p < 0.001). Log [EPO] was slightly increased in the CMS group relative to the HH group (p < 0.01). All values in the IM group were between those in the HH and CMS groups. Hbmass and BV were positively correlated, and PV was negatively correlated with peripheral O2 saturation. Increased Hbmass and decreased PV contributed approximately 65 and 35%, respectively, to the difference in [Hb] between the HH (17.1 ± 0.8 g/dl) and CMS (22.1 ± 1.0 g/dl) groups. Conclusions: In CMS patients, the decrease in PV only partially compensated for the substantial increase in Hbmass, but it did not prevent an increase in BV; the decrease in PV contributed to an excessively high [Hb].https://www.frontiersin.org/articles/10.3389/fphys.2022.867108/fullchronic mountain sicknesshemoglobin concentrationplasma volumecarbon monoxide rebreathingerythropoietinperipheral oxygen saturation
spellingShingle Walter F. J. Schmidt
Nadine Wachsmuth
Jesus Jimenez
Rudy Soria
Hemoglobin Mass and Blood Volume in Patients With Altitude-Related Polycythemia
Frontiers in Physiology
chronic mountain sickness
hemoglobin concentration
plasma volume
carbon monoxide rebreathing
erythropoietin
peripheral oxygen saturation
title Hemoglobin Mass and Blood Volume in Patients With Altitude-Related Polycythemia
title_full Hemoglobin Mass and Blood Volume in Patients With Altitude-Related Polycythemia
title_fullStr Hemoglobin Mass and Blood Volume in Patients With Altitude-Related Polycythemia
title_full_unstemmed Hemoglobin Mass and Blood Volume in Patients With Altitude-Related Polycythemia
title_short Hemoglobin Mass and Blood Volume in Patients With Altitude-Related Polycythemia
title_sort hemoglobin mass and blood volume in patients with altitude related polycythemia
topic chronic mountain sickness
hemoglobin concentration
plasma volume
carbon monoxide rebreathing
erythropoietin
peripheral oxygen saturation
url https://www.frontiersin.org/articles/10.3389/fphys.2022.867108/full
work_keys_str_mv AT walterfjschmidt hemoglobinmassandbloodvolumeinpatientswithaltituderelatedpolycythemia
AT nadinewachsmuth hemoglobinmassandbloodvolumeinpatientswithaltituderelatedpolycythemia
AT jesusjimenez hemoglobinmassandbloodvolumeinpatientswithaltituderelatedpolycythemia
AT rudysoria hemoglobinmassandbloodvolumeinpatientswithaltituderelatedpolycythemia